Member Info for JOHNO77

I think it was a very encouraging update CM. A few taking profits is natural, i think we will now see the start of a new upward direction over the next couple of months.

Let him get on with it mate if he wants to sell for beer money

Very encouraging update. Dispersion work going very well it seems.... all on target to achieve the studies objectives:

‘The first two stages of phase one of the in vitro work have now been completed. The Company has manufactured a new batch of Nuvec® using an improved process and has successfully demonstrated that the Nuvec® particle can be effectively and repeatedly dispersed into a more monodisperse formulation, prior to the addition of DNA. The Company expects that this more monodisperse formulation will result in a more even distribution of DNA across the Nuvec® nanoparticles, thereby resulting in a more monodisperse formulation of DNA loaded Nuvec®.’

Decent day - let’s hope for the same tomorrow.

Beginning of a run????

Still around on twitter under a different name(s)......

16% gain last week
0% gain wk before
11% gain 1st full week of year
25% gain since 31st Dec.

Not bad, keeping it nice & steady. Another push higher next week?????

...but hopefully only for a day or two. Overdue an update so lets hope investors get what they have been waiting for.

Loose 50% or Multibag? That is the big question.... Market seems scared to dive in until firm news of progression which is understandable. If that comes then we'll be seeing a repeat of 2018...:))))

Someone's had a little nibble today. Great entry level to be fair... mcap less than 2 mill.... I'm sure someone once said buy low, sell high???? lol... Gotta decent chance of making that work buying down here.

The percussion programme hasn't got the markets juices flowing, that's for sure, but it will help to whittle down the prospective targets before the core drilling program.

Been holding for what seems like an age but think this will get much higher at some point within the 12 months.

With the mcap still at 4mill this is very early days still.

If we receive a decent update from the latest set of studies there are surely not many shares out there with a better chance of multibagging than N4P.

Obviously nothing guaranteed but IMO can't get much better in terms of risk / reward!

Any small rise on anticipation will surely be small fry compared to the re-rate N4 COULD see upon improved Results.

The co would ideally want to go it alone if they can afford it but as you know AstraZeneca were involved last year and will surely want to be involved again should the results show improved consistency. I’m sure many others would be sniffing around too upon good results - the beauty of the the multi licence business model...

What’s the consensus here.... Do people think that this will rise on anticipation of improved Nuvec results?

News imminent from Nuvec studies. Daily chart looking very good. SP above 50 MA & EMA for 1st time in a long while. Historically when this has happened we have seen a decent move so looking promising here...

3.49 paid through NEX...

Nice to see more activity today. Surely not long to go until the next update.

Looking at the current mCap the returns could be huge from here If the current studies go to plan....

Some chunky buys coming in today...

lol

Agreed Leister - N4 is defo due for news to start coming through during this quarter.

If the news is positive then surely the only way is up from 3p.

Muppet

Agreed Mazik, this has the potential to replicate the big move we saw during early 2018.

:)))

From results RNS: 'The Company is pleased to announce that analysis of its pDNA OVA findings has again demonstrated that, after three injections, Nuvec® produces an immune response capable of delivering a very clear increase in the number of antibodies specific for OVA in the 1:20 and 1:30 doses, where all test cases (6/6) responded.'

It is shown to work using 3 injections so now is a matter of tweaking the loading etc to improve consistency using less injections.

Even if it requires 3 injections, surely a partner would want to trial Nuvec for their product?

SP drifting on lack of news but updates are due as N4 completes each stage of it's current work programme (all detailed in interims).

Hopefully 2020 will provide some upside for N4P.

The constant deramping is sounding a bit desperate from a few of you now.....

Yawn...